SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Prenatal Diagnosis has published a ...

AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency ...

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates. In clinical practice, indirect ...

Single-cell sequencing to elucidate the disparities in the immune microenvironment between PIK3CA mutants and wild types. Sintilimab and anlotinib combination therapy in PD-L1-positive ...